Citadel Advisors’s Cullinan Oncology CGEM Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $11.8M | Sell |
|
|||||
|
2025
Q2 | $19.7M | Sell |
|
|||||
|
2025
Q1 | $20.8M | Buy |
|
|||||
|
2024
Q4 | $32.7M | Buy |
|
|||||
|
2024
Q3 | $32.7M | Buy |
|
|||||
|
2024
Q2 | $33.9M | Buy |
|
|||||
|
2024
Q1 | $18.9M | Sell |
|
|||||
|
2023
Q4 | $11.5M | Buy |
|
|||||
|
2023
Q3 | $9.64M | Buy |
|
|||||
|
2023
Q2 | $11.4M | Buy |
|
|||||
|
2023
Q1 | $6.37M | Buy |
|
|||||
|
2022
Q4 | $2.59M | Buy |
|
|||||
|
2022
Q3 | $3.02M | Sell |
|
|||||
|
2022
Q2 | $4.74M | Buy |
|
|||||
|
2022
Q1 | $1.46M | Buy |
|
|||||
|
2021
Q4 | $717K | Sell |
|
|||||
|
2021
Q3 | $2.4M | Buy |
|
|||||
|
2021
Q2 | $2.65M | Sell |
|
|||||
|
2021
Q1 | $4.64M | Buy |
|